Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

被引：3
|
作者：
Tuepker, J [1 ]
机构：
[1] Texas Tech Univ, Sch Pharm, Dallas, TX USA
来源：
CIRCULATION | 2003年 / 107卷 / 16期
关键词：
D O I：
10.1161/01.CIR.0000067693.46108.2D
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E109 / E109
页数：1
相关论文
共 50 条
  • [1] Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
    Haffner, SM
    Greenberg, AS
    Weston, WM
    Chen, HZ
    Williams, K
    Freed, MI
    [J]. CIRCULATION, 2002, 106 (06) : 679 - 684
  • [2] Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
    Chu, CS
    Lee, KT
    Lee, MY
    Su, HM
    Voon, WC
    Sheu, SH
    Lai, WT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (05): : 646 - 650
  • [3] The effect of glipizide, metformin and rosiglitazone on nontraditional cardiovascular risk factors in newly diagnosed patients with type 2 diabetes mellitus
    Gupta, Rajesh K.
    Rehan, Harmeet S.
    Rohatagi, Anurag
    Bhatacharjee, Jayashree
    Chopra, Deepti
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2010, 30 (03) : 123 - 128
  • [4] Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
    Hertzel C Gerstein
    Salim Yusuf
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 798 - 799
  • [5] A comparison of nontraditional atherogenic markers with pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
    Law, R
    Khan, M
    Perez, A
    Jacober, S
    Goldberg, R
    Kendall, D
    Deeg, M
    Tan, M
    Demissie, S
    [J]. DIABETOLOGIA, 2005, 48 : A286 - A286
  • [6] The Effect of Rosiglitazone on the Expression of Thrombogenic Markers on Leukocytes in Type 2 Diabetes Mellitus
    Svobodova, H.
    Stulc, T.
    Kasalova, Z.
    Dolezalova, R.
    Marinov, I.
    Capek, P.
    Ceska, R.
    [J]. PHYSIOLOGICAL RESEARCH, 2009, 58 (05) : 701 - 707
  • [7] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    [J]. PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [8] Effect of Liraglutide on Cardiovascular Markers in Type 2 Diabetes Mellitus
    Ren, Wei
    Guo, Jianjin
    Liu, Jie
    Xi, Guangxia
    [J]. DIABETES, 2015, 64 : A339 - A339
  • [9] The effect of meal composition on cardiovascular markers in patients with type 2 diabetes mellitus.
    Panja, SR
    Barchie, M
    Colleran, KM
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S107 - S107
  • [10] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    [J]. DIABETOLOGIA, 2012, 55 : S310 - S311
12345